Loading…

Percutaneous thrombectomy in patients with massive and very high‐risk submassive acute pulmonary embolism

Objective Examine FlowTriever thrombectomy feasibility in high‐risk PE patients. Background The FlowTriever thrombectomy system (Inari Medical, Irvine, CA) can reduce right ventricle (RV) strain in acute submassive pulmonary embolism (PE) patients. This technology has not been studied in higher risk...

Full description

Saved in:
Bibliographic Details
Published in:Catheterization and cardiovascular interventions 2020-12, Vol.96 (7), p.1465-1470
Main Authors: Toma, Catalin, Khandhar, Sameer, Zalewski, Adrian M., D'Auria, Stephen J., Tu, Thomas M., Jaber, Wissam A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3536-dcb2d324826fea8e89eb88a91e0ff6c63c2e4a79fa55d2bb27eb03d911e79ebb3
cites cdi_FETCH-LOGICAL-c3536-dcb2d324826fea8e89eb88a91e0ff6c63c2e4a79fa55d2bb27eb03d911e79ebb3
container_end_page 1470
container_issue 7
container_start_page 1465
container_title Catheterization and cardiovascular interventions
container_volume 96
creator Toma, Catalin
Khandhar, Sameer
Zalewski, Adrian M.
D'Auria, Stephen J.
Tu, Thomas M.
Jaber, Wissam A.
description Objective Examine FlowTriever thrombectomy feasibility in high‐risk PE patients. Background The FlowTriever thrombectomy system (Inari Medical, Irvine, CA) can reduce right ventricle (RV) strain in acute submassive pulmonary embolism (PE) patients. This technology has not been studied in higher risk PE patients. Methods This multicenter retrospective analysis included patients treated with FlowTriever between 2017 and 2019 if they met at least one of the following: vasopressor dependence, PE induced respiratory failure, or decreased cardiac index (CI) measured by right heart catheterization. Results Analysis included 34 patients: 18 massive, four intubated, 12 normotensive but with CI 
doi_str_mv 10.1002/ccd.29246
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2439622209</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2439622209</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3536-dcb2d324826fea8e89eb88a91e0ff6c63c2e4a79fa55d2bb27eb03d911e79ebb3</originalsourceid><addsrcrecordid>eNp10ctO3DAUBmALFcFwWfQFkKVu6GIY-zhx4mU1UIqERBdFYhfZzknHkMtgJzOaHY_AM_IkuGRgUYmVLfnTL5_zE_KVszPOGMysLc9AQSJ3yISnANMM5N2X7Z2rRO6TgxDuGWNKgtoj-wJyKUWSTsjDb_R26HWL3RBov_BdY9D2XbOhrqVL3Tts-0DXrl_QRofgVkh1W9IV-g1duL-Ll6dn78IDDYP5eI-BSJdD3XStjgwb09UuNEdkt9J1wOPteUhuf178mf-aXt9cXs1_XE-tSIWcltZAKSDJQVaoc8wVmjzXiiOrKmmlsICJzlSl07QEYyBDw0SpOMcsUiMOyemYu_Td44ChLxoXLNb1OGUBiYh7AGAq0m__0ftu8G38XVRSccjSTET1fVTWdyF4rIqld00creCs-NdAERso3hqI9mSbGBeC5Yd8X3kEsxGsXY2bz5OK-fx8jHwFhkuTKQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2469127573</pqid></control><display><type>article</type><title>Percutaneous thrombectomy in patients with massive and very high‐risk submassive acute pulmonary embolism</title><source>Wiley</source><creator>Toma, Catalin ; Khandhar, Sameer ; Zalewski, Adrian M. ; D'Auria, Stephen J. ; Tu, Thomas M. ; Jaber, Wissam A.</creator><creatorcontrib>Toma, Catalin ; Khandhar, Sameer ; Zalewski, Adrian M. ; D'Auria, Stephen J. ; Tu, Thomas M. ; Jaber, Wissam A.</creatorcontrib><description>Objective Examine FlowTriever thrombectomy feasibility in high‐risk PE patients. Background The FlowTriever thrombectomy system (Inari Medical, Irvine, CA) can reduce right ventricle (RV) strain in acute submassive pulmonary embolism (PE) patients. This technology has not been studied in higher risk PE patients. Methods This multicenter retrospective analysis included patients treated with FlowTriever between 2017 and 2019 if they met at least one of the following: vasopressor dependence, PE induced respiratory failure, or decreased cardiac index (CI) measured by right heart catheterization. Results Analysis included 34 patients: 18 massive, four intubated, 12 normotensive but with CI &lt; 1.8. Average age was 56 and their median simplified PE severity index was 2. Patients had high bleeding risk, with 13 having recent surgery, six posttrauma, and four recent strokes. Six patients received cardiopulmonary resuscitation, and two received additional mechanical circulatory support. All patients had RV dilatation and elevated biomarkers. Clot removal was successful in 32/34 patients. CI improved from 2.0 ± 0.1 L/min/m2 before thrombectomy to 2.4 ± 0.1 L/min/m2 after (p = .01). The mean pulmonary artery pressure decreased from 33.2 ± 1.6 mmHg to 25.0 ± 1.5 mmHg (p = .01). The two patients—both with no or minimal thrombus removed—deteriorated during the procedure: one died and the other was successfully stabilized on ECMO. There were no other major complications. All other patients were alive at the time of data collection (mean follow‐up of 205 days). Conclusion Aspiration thrombectomy appears feasible in higher risk acute PE patients with immediate hemodynamic improvement and low in‐hospital mortality.</description><identifier>ISSN: 1522-1946</identifier><identifier>EISSN: 1522-726X</identifier><identifier>DOI: 10.1002/ccd.29246</identifier><identifier>PMID: 32866345</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>cardiac index ; cardiogenic shock ; Catheterization ; Embolism ; Patients ; Pulmonary arteries ; Pulmonary artery ; Pulmonary embolisms ; Respiratory failure ; sPESI ; Surgery ; Thrombosis ; Ventricle</subject><ispartof>Catheterization and cardiovascular interventions, 2020-12, Vol.96 (7), p.1465-1470</ispartof><rights>2020 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3536-dcb2d324826fea8e89eb88a91e0ff6c63c2e4a79fa55d2bb27eb03d911e79ebb3</citedby><cites>FETCH-LOGICAL-c3536-dcb2d324826fea8e89eb88a91e0ff6c63c2e4a79fa55d2bb27eb03d911e79ebb3</cites><orcidid>0000-0003-0187-2962</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32866345$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Toma, Catalin</creatorcontrib><creatorcontrib>Khandhar, Sameer</creatorcontrib><creatorcontrib>Zalewski, Adrian M.</creatorcontrib><creatorcontrib>D'Auria, Stephen J.</creatorcontrib><creatorcontrib>Tu, Thomas M.</creatorcontrib><creatorcontrib>Jaber, Wissam A.</creatorcontrib><title>Percutaneous thrombectomy in patients with massive and very high‐risk submassive acute pulmonary embolism</title><title>Catheterization and cardiovascular interventions</title><addtitle>Catheter Cardiovasc Interv</addtitle><description>Objective Examine FlowTriever thrombectomy feasibility in high‐risk PE patients. Background The FlowTriever thrombectomy system (Inari Medical, Irvine, CA) can reduce right ventricle (RV) strain in acute submassive pulmonary embolism (PE) patients. This technology has not been studied in higher risk PE patients. Methods This multicenter retrospective analysis included patients treated with FlowTriever between 2017 and 2019 if they met at least one of the following: vasopressor dependence, PE induced respiratory failure, or decreased cardiac index (CI) measured by right heart catheterization. Results Analysis included 34 patients: 18 massive, four intubated, 12 normotensive but with CI &lt; 1.8. Average age was 56 and their median simplified PE severity index was 2. Patients had high bleeding risk, with 13 having recent surgery, six posttrauma, and four recent strokes. Six patients received cardiopulmonary resuscitation, and two received additional mechanical circulatory support. All patients had RV dilatation and elevated biomarkers. Clot removal was successful in 32/34 patients. CI improved from 2.0 ± 0.1 L/min/m2 before thrombectomy to 2.4 ± 0.1 L/min/m2 after (p = .01). The mean pulmonary artery pressure decreased from 33.2 ± 1.6 mmHg to 25.0 ± 1.5 mmHg (p = .01). The two patients—both with no or minimal thrombus removed—deteriorated during the procedure: one died and the other was successfully stabilized on ECMO. There were no other major complications. All other patients were alive at the time of data collection (mean follow‐up of 205 days). Conclusion Aspiration thrombectomy appears feasible in higher risk acute PE patients with immediate hemodynamic improvement and low in‐hospital mortality.</description><subject>cardiac index</subject><subject>cardiogenic shock</subject><subject>Catheterization</subject><subject>Embolism</subject><subject>Patients</subject><subject>Pulmonary arteries</subject><subject>Pulmonary artery</subject><subject>Pulmonary embolisms</subject><subject>Respiratory failure</subject><subject>sPESI</subject><subject>Surgery</subject><subject>Thrombosis</subject><subject>Ventricle</subject><issn>1522-1946</issn><issn>1522-726X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp10ctO3DAUBmALFcFwWfQFkKVu6GIY-zhx4mU1UIqERBdFYhfZzknHkMtgJzOaHY_AM_IkuGRgUYmVLfnTL5_zE_KVszPOGMysLc9AQSJ3yISnANMM5N2X7Z2rRO6TgxDuGWNKgtoj-wJyKUWSTsjDb_R26HWL3RBov_BdY9D2XbOhrqVL3Tts-0DXrl_QRofgVkh1W9IV-g1duL-Ll6dn78IDDYP5eI-BSJdD3XStjgwb09UuNEdkt9J1wOPteUhuf178mf-aXt9cXs1_XE-tSIWcltZAKSDJQVaoc8wVmjzXiiOrKmmlsICJzlSl07QEYyBDw0SpOMcsUiMOyemYu_Td44ChLxoXLNb1OGUBiYh7AGAq0m__0ftu8G38XVRSccjSTET1fVTWdyF4rIqld00creCs-NdAERso3hqI9mSbGBeC5Yd8X3kEsxGsXY2bz5OK-fx8jHwFhkuTKQ</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Toma, Catalin</creator><creator>Khandhar, Sameer</creator><creator>Zalewski, Adrian M.</creator><creator>D'Auria, Stephen J.</creator><creator>Tu, Thomas M.</creator><creator>Jaber, Wissam A.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0187-2962</orcidid></search><sort><creationdate>202012</creationdate><title>Percutaneous thrombectomy in patients with massive and very high‐risk submassive acute pulmonary embolism</title><author>Toma, Catalin ; Khandhar, Sameer ; Zalewski, Adrian M. ; D'Auria, Stephen J. ; Tu, Thomas M. ; Jaber, Wissam A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3536-dcb2d324826fea8e89eb88a91e0ff6c63c2e4a79fa55d2bb27eb03d911e79ebb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>cardiac index</topic><topic>cardiogenic shock</topic><topic>Catheterization</topic><topic>Embolism</topic><topic>Patients</topic><topic>Pulmonary arteries</topic><topic>Pulmonary artery</topic><topic>Pulmonary embolisms</topic><topic>Respiratory failure</topic><topic>sPESI</topic><topic>Surgery</topic><topic>Thrombosis</topic><topic>Ventricle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Toma, Catalin</creatorcontrib><creatorcontrib>Khandhar, Sameer</creatorcontrib><creatorcontrib>Zalewski, Adrian M.</creatorcontrib><creatorcontrib>D'Auria, Stephen J.</creatorcontrib><creatorcontrib>Tu, Thomas M.</creatorcontrib><creatorcontrib>Jaber, Wissam A.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Catheterization and cardiovascular interventions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Toma, Catalin</au><au>Khandhar, Sameer</au><au>Zalewski, Adrian M.</au><au>D'Auria, Stephen J.</au><au>Tu, Thomas M.</au><au>Jaber, Wissam A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Percutaneous thrombectomy in patients with massive and very high‐risk submassive acute pulmonary embolism</atitle><jtitle>Catheterization and cardiovascular interventions</jtitle><addtitle>Catheter Cardiovasc Interv</addtitle><date>2020-12</date><risdate>2020</risdate><volume>96</volume><issue>7</issue><spage>1465</spage><epage>1470</epage><pages>1465-1470</pages><issn>1522-1946</issn><eissn>1522-726X</eissn><abstract>Objective Examine FlowTriever thrombectomy feasibility in high‐risk PE patients. Background The FlowTriever thrombectomy system (Inari Medical, Irvine, CA) can reduce right ventricle (RV) strain in acute submassive pulmonary embolism (PE) patients. This technology has not been studied in higher risk PE patients. Methods This multicenter retrospective analysis included patients treated with FlowTriever between 2017 and 2019 if they met at least one of the following: vasopressor dependence, PE induced respiratory failure, or decreased cardiac index (CI) measured by right heart catheterization. Results Analysis included 34 patients: 18 massive, four intubated, 12 normotensive but with CI &lt; 1.8. Average age was 56 and their median simplified PE severity index was 2. Patients had high bleeding risk, with 13 having recent surgery, six posttrauma, and four recent strokes. Six patients received cardiopulmonary resuscitation, and two received additional mechanical circulatory support. All patients had RV dilatation and elevated biomarkers. Clot removal was successful in 32/34 patients. CI improved from 2.0 ± 0.1 L/min/m2 before thrombectomy to 2.4 ± 0.1 L/min/m2 after (p = .01). The mean pulmonary artery pressure decreased from 33.2 ± 1.6 mmHg to 25.0 ± 1.5 mmHg (p = .01). The two patients—both with no or minimal thrombus removed—deteriorated during the procedure: one died and the other was successfully stabilized on ECMO. There were no other major complications. All other patients were alive at the time of data collection (mean follow‐up of 205 days). Conclusion Aspiration thrombectomy appears feasible in higher risk acute PE patients with immediate hemodynamic improvement and low in‐hospital mortality.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>32866345</pmid><doi>10.1002/ccd.29246</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-0187-2962</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1522-1946
ispartof Catheterization and cardiovascular interventions, 2020-12, Vol.96 (7), p.1465-1470
issn 1522-1946
1522-726X
language eng
recordid cdi_proquest_miscellaneous_2439622209
source Wiley
subjects cardiac index
cardiogenic shock
Catheterization
Embolism
Patients
Pulmonary arteries
Pulmonary artery
Pulmonary embolisms
Respiratory failure
sPESI
Surgery
Thrombosis
Ventricle
title Percutaneous thrombectomy in patients with massive and very high‐risk submassive acute pulmonary embolism
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T17%3A11%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Percutaneous%20thrombectomy%20in%20patients%20with%20massive%20and%20very%20high%E2%80%90risk%20submassive%20acute%20pulmonary%20embolism&rft.jtitle=Catheterization%20and%20cardiovascular%20interventions&rft.au=Toma,%20Catalin&rft.date=2020-12&rft.volume=96&rft.issue=7&rft.spage=1465&rft.epage=1470&rft.pages=1465-1470&rft.issn=1522-1946&rft.eissn=1522-726X&rft_id=info:doi/10.1002/ccd.29246&rft_dat=%3Cproquest_cross%3E2439622209%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3536-dcb2d324826fea8e89eb88a91e0ff6c63c2e4a79fa55d2bb27eb03d911e79ebb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2469127573&rft_id=info:pmid/32866345&rfr_iscdi=true